Uncategorized
Uncategorized · page 39
- Uncategorized
US Cannabis Stock Prices up 25% Since Publication of Rescheduling Recommendation
US cannabis stock prices have rallied once again this week following the publication of the fully unredacted 252-page cannabis rescheduling recommendation.
- Uncategorized
Teva Pharmaceuticals Fails to Disqualify Jazz Pharmaceuticals’ Epidyolex Patent In Court
Jazz Pharmaceuticals has rebuffed attempts by rival Teva Pharmaceuticals to legally disqualify its patent for Epidyolex, a cannabis-based drug worth hundreds of millions of dollars a year.
- Uncategorized
Colorado’s Cannabis Market Hit Lowest Sales Since 2015 in November 2023
Colorado’s cannabis market continued its substantial decline in the closing months of 2023, seeing cannabis sales fall to their lowest level since February 2015 in November.
- Uncategorized
US Government Releases Full Unredacted Cannabis Rescheduling Recommendation, Confirming Medical Uses
The fully unredacted 252-page cannabis rescheduling recommendation has finally been made public, confirming for the first time that cannabis has medical uses.
- Uncategorized
Deutsche Verbände für medizinisches Cannabis fordern eine umfassendere Regulierungsreform
Wie berichtet von Cannabis Gesundheit Deutsche Verbände haben eine umfassende Reform der Vorschriften für medizinisches Cannabis gefordert, um “Bürokratie abzubauen” und den Zugang für Patienten zu erleichtern.
- Uncategorized
Wisconsin’s Restrictive Medical Cannabis Plans Could ‘Limit Patient Access’
More details regarding Wisconsin’s highly restrictive plans to legalise medical cannabis have emerged, seeing some experts raise ‘significant concerns’.
- Uncategorized
More Than 2m Low-Level Cannabis Offenses Expunged Since 2018
State and local US courts have expunged or sealed the records of an estimated 2.3 million cannabis cases since 2018, new analysis from the National Organization for the Reform of Marijuana Laws (NORML) suggests.
- Uncategorized
Tilray Sees Stock Fall 10% Despite Record Revenues in Q2
Tilray has reported another quarter of record sales while beating analysts’ estimates on its earnings, reducing its losses by around US$15m year-on-year.
- Uncategorized
Maryland’s Annual Cannabis Sales Hit $700m Since Adult-Use Legalisation
New figures from the Maryland Cannabis Administration show that since adult-use cannabis was legalised in July 2023, recreational sales have grown to over $270m.
- Uncategorized
Congressman Urges DEA to Act Quickly on Rescheduling
In a letter to the US Drug Enforcement Agency (DEA), Congressman Steve Cohen has called on the agency to ‘act expeditiously’ on the Department of Health and Human Services (HHS) recommendation to reschedule cannabis.
- Uncategorized
Wisconsin Could Soon Legalise Medical Cannabis, But Access Expected to be Extremely Limited
Medical cannabis could be made legal in Wisconsin this year as the state’s Democrat Governor indicates he’s willing to sign a Republican-led bill.
- Uncategorized
Canadian Cannabis Legalization Not Linked to Increase in Cannabis-Related Psychosis, Study Reports
Canadian researchers have found that the legalization of cannabis in Canada is not associated with higher rates of cannabis-related psychosis.
